| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
76,182,000 |
| Market
Cap: |
13.21(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$127.77 - $330.23 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 882 |
| Guru Rank Value : 0.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System and the Omnipod DASH™ Insulin Management System, its digital mobile Omnipod platform. The Omnipod System features: a small, self-adhesive disposable tubeless Omnipod device (Pod) that the user fills with insulin and wears directly on the body; and the Personal Diabetes Manager, a wireless, handheld device that programs the Pod with the user's personalized insulin-delivery instructions and, wirelessly monitors the Pod's operation.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
5,551 |
8,851 |
| Total Buy Value |
$0 |
$0 |
$1,006,995 |
$2,012,670 |
| Total People Bought |
0 |
0 |
2 |
3 |
| Total Buy Transactions |
0 |
0 |
2 |
3 |
| Total Shares Sold |
3,300 |
14,981 |
52,044 |
170,562 |
| Total Sell Value |
$596,970 |
$2,503,218 |
$8,850,279 |
$40,925,357 |
| Total People Sold |
1 |
3 |
5 |
8 |
| Total Sell Transactions |
1 |
3 |
8 |
21 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Thomas Bradley A |
EVP Human Resources |
• • – |
2015-12-01 |
4 |
D |
$37.27 |
$73,534 |
D/D |
(1,973) |
30,358 |
|
- |
|
| Thomas Bradley A |
EVP Human Resources |
• • – |
2015-08-20 |
4 |
B |
$29.41 |
$24,851 |
D/D |
845 |
32,331 |
2.74 |
- |
|
| Hopfield Jessica |
Director |
• • – |
2015-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,608 |
5,608 |
|
- |
|
| Colleran David |
Secretary and General CounselO |
• – – |
2015-07-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,627 |
|
- |
|
| Sullivan Patrick J |
President & CEO |
• • – |
2015-06-05 |
4 |
B |
$29.39 |
$293,880 |
D/D |
10,000 |
83,650 |
2.81 |
- |
|
| Sullivan Patrick J |
President & CEO |
• • – |
2015-05-28 |
4 |
B |
$27.74 |
$558,170 |
D/D |
20,000 |
73,650 |
2.81 |
- |
|
| Scannell Timothy J |
Director |
• • – |
2015-05-15 |
4 |
B |
$27.05 |
$94,675 |
D/D |
3,500 |
12,120 |
2.81 |
- |
|
| Scannell Timothy J |
Director |
• • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,039 |
8,620 |
|
- |
|
| Zakrzewski Joseph S |
Director |
• • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,039 |
24,039 |
|
- |
|
| Sommer Regina O |
Director |
• • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,039 |
24,539 |
|
- |
|
| Sobieski Steven |
Director |
• • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,039 |
16,039 |
|
- |
|
| Fallon John A. |
Director |
• • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,039 |
12,039 |
|
- |
|
| Crawford Sally |
Director |
• • – |
2015-05-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,039 |
18,039 |
|
- |
|
| Diehl R Anthony |
Secretary and General Counsel |
• • – |
2015-05-11 |
4 |
OE |
$15.09 |
$151,544 |
D/D |
10,017 |
40,854 |
|
- |
|
| Diehl R Anthony |
Secretary and General Counsel |
• • – |
2015-05-11 |
4 |
AS |
$26.63 |
$332,875 |
D/D |
(12,500) |
30,837 |
|
- |
|
| Ryan Patrick |
Chief Operating Officer |
• • – |
2015-05-05 |
4 |
B |
$26.99 |
$99,026 |
D/D |
3,669 |
47,990 |
2.74 |
- |
|
| Thomas Bradley A |
EVP Human Resources |
• • – |
2015-05-05 |
4 |
B |
$27.26 |
$27,260 |
D/D |
1,000 |
31,486 |
2.74 |
- |
|
| Levitz Michael L |
CFO |
• • – |
2015-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
43,028 |
43,028 |
|
- |
|
| Levangie Daniel J |
President, Drug Delivery |
• • – |
2015-04-30 |
4 |
D |
$29.85 |
$39,909 |
D/D |
(1,337) |
10,663 |
|
- |
|
| Diehl R Anthony |
Secretary and General Counsel |
• • – |
2015-04-02 |
4 |
AS |
$30.96 |
$104,397 |
D/D |
(3,372) |
43,337 |
|
- |
|
| Diehl R Anthony |
Secretary and General Counsel |
• • – |
2015-04-01 |
4 |
D |
$31.85 |
$51,852 |
D/D |
(1,628) |
46,709 |
|
- |
|
| Dorval Allison |
Chief Financial Officer |
• • – |
2015-04-01 |
4 |
D |
$31.85 |
$25,926 |
D/D |
(814) |
37,415 |
|
- |
|
| Liamos Charles T |
Director |
• • – |
2015-04-01 |
4 |
D |
$31.85 |
$95,773 |
D/D |
(3,007) |
87,575 |
|
- |
|
| Liamos Charles T |
Director |
• • – |
2015-04-01 |
4 |
AS |
$33.16 |
$132,640 |
D/D |
(4,000) |
90,582 |
|
- |
|
| Liamos Charles T |
Director |
• • – |
2015-04-01 |
4 |
OE |
$15.82 |
$63,280 |
D/D |
4,000 |
94,582 |
|
- |
|
683 Records found
|
|
Page 25 of 28 |
|
|
3.15 (1.85%) 
